Sarah D Diermeier (Sarah Diermeier)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Network Analysis

Radical Prostatectomy

Papillary Thyroid

Long Noncoding Rna

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

William J H Davis, Catherine J Drummond, Sarah D Diermeier, Glen Reid
The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma. Genes 15 (7) (2024)
William J H Davis, Catherine J Drummond, Sarah D Diermeier, Glen Reid
The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma. Genes 15 (7) (2024)
William J H Davis, Catherine J Drummond, Sarah D Diermeier, Glen Reid
The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma. Genes 15 (7) (2024)
Manojit M Swamynathan, Grinu Mathew, Andrei Aziz, Chris Gordon, Andrew Hillowe, Hehe Wang, Aashna Jhaveri, Jude Kendall, Hilary Cox, Michael Giarrizzo, Gissou Azabdaftari, Robert C Rizzo, Sarah D Diermeier, Iwao Ojima, Agnieszka B Bialkowska, Martin Kaczocha, Lloyd C Trotman
FABP5 Inhibition against PTEN -Mutant Therapy Resistant Prostate Cancer. Cancers 16 (1) (2023)
Manojit M Swamynathan, Grinu Mathew, Andrei Aziz, Chris Gordon, Andrew Hillowe, Hehe Wang, Aashna Jhaveri, Jude Kendall, Hilary Cox, Michael Giarrizzo, Gissou Azabdaftari, Robert C Rizzo, Sarah D Diermeier, Iwao Ojima, Agnieszka B Bialkowska, Martin Kaczocha, Lloyd C Trotman
FABP5 Inhibition against PTEN -Mutant Therapy Resistant Prostate Cancer. Cancers 16 (1) (2023)
Manojit M Swamynathan, Grinu Mathew, Andrei Aziz, Chris Gordon, Andrew Hillowe, Hehe Wang, Aashna Jhaveri, Jude Kendall, Hilary Cox, Michael Giarrizzo, Gissou Azabdaftari, Robert C Rizzo, Sarah D Diermeier, Iwao Ojima, Agnieszka B Bialkowska, Martin Kaczocha, Lloyd C Trotman
FABP5 Inhibition against PTEN -Mutant Therapy Resistant Prostate Cancer. Cancers 16 (1) (2023)
Holly R Pinkney, Michael A Black, Sarah D Diermeier
Single-Cell RNA-Seq Reveals Heterogeneous lncRNA Expression in Xenografted Triple-Negative Breast Cancer Cells. Biology 10 (10) (2021)
Zohaib Rana, Sarah D Diermeier, Fearghal P Walsh, Muhammad Hanif, Christian G Hartinger, Rhonda J Rosengren
Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Colin Timaxian, Christoph F A Vogel, Charlotte Orcel, Diana Vetter, Camille Durochat, Clarisse Chinal, Phuong NGuyen, Marie-Laure Aknin, Françoise Mercier-Nomé, Martin Davy, Isabelle Raymond-Letron, Thi-Nhu-Ngoc Van, Sarah D Diermeier, Anastasia Godefroy, Magali Gary-Bobo, Franck Molina, Karl Balabanian, Gwendal Lazennec
Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer. Cancers 13 (11) (2021)
Debina Sarkar, Sarah D Diermeier
Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer. Non-coding RNA 7 (1) (2021)
Haoyu Xiong, Rakesh N Veedu, Sarah D Diermeier
Recent Advances in Oligonucleotide Therapeutics in Oncology. International journal of molecular sciences 22 (7) (2021)
Prithi Raguraman, Akilandeswari Ashwini Balachandran, Suxiang Chen, Sarah D Diermeier, Rakesh N Veedu
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation. Cancers 13 (21) (2021)
Kung-Chi Chang, Sarah D Diermeier, Allen T Yu, Lily D Brine, Suzanne Russo, Sonam Bhatia, Habeeb Alsudani, Karen Kostroff, Tawfiqul Bhuiya, Edi Brogi, Darryl J Pappin, C Frank Bennett, Frank Rigo, David L Spector
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression. Nature communications 11 (1) (2020)
Holly R Pinkney, Brandon M Wright, Sarah D Diermeier
The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis. Non-coding RNA 6 (4) (2020)
Kathleen M Lucere, Megan M R O'Malley, Sarah D Diermeier
Functional Screening Techniques to Identify Long Non-Coding RNAs as Therapeutic Targets in Cancer. Cancers 12 (12) (2020)